Cereno Scientific
Cereno Scientific develops therapies for cardiovascular diseases using epigenetic modulation and advances drug candidates like CS1.
About Cereno Scientific
Cereno Scientific AB develops a new innovative treatment for patients with increased risk of blood clotting, based on the company's newly patented research findings. Cereno Scientific AB develops drugs that normalize the body's own defense system against blood clots for the treatment of complications in cardiovascular diseases.
Company Facts
- Headquarters
- M├╢lndal
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00011_00050
- Funding Stage
- ipo
- Total Funding
- $86,937,207
- Last Funding Type
- post_ipo_equity
- Last Funding Date
- 2025-11-28
- Website
- cerenoscientific.com
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Medical, Pharmaceutical, Therapeutics
Social Links
Canonical: https://fsome.com/organization/cereno-scientific-64379 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.